BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 9572317)

  • 1. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.
    Griffin MR
    Am J Med; 1998 Mar; 104(3A):23S-29S; discussion 41S-42S. PubMed ID: 9572317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of nonsteroidal anti-inflammatory drugs.
    Tenenbaum J
    Can J Gastroenterol; 1999 Mar; 13(2):119-22. PubMed ID: 10203429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
    Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
    CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary care.
    Hollenz M; Stolte M; Leodolter A; Labenz J
    Dig Dis; 2006; 24(1-2):189-94. PubMed ID: 16699277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Induced Dyspepsia.
    Yap PR; Goh KL
    Curr Pharm Des; 2015; 21(35):5073-81. PubMed ID: 26369685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis?
    Goldstein JL
    Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S11-5. PubMed ID: 10929893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drugs and gastrointestinal disease: pathophysiology, treatment and prevention.
    Bjorkman DJ; Kimmey MB
    Dig Dis; 1995; 13(2):119-29. PubMed ID: 7586632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease.
    Visser LE; Graatsma HH; Stricker BH
    Br J Clin Pharmacol; 2002 Feb; 53(2):183-8. PubMed ID: 11851642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis.
    El-Serag HB; Graham DY; Richardson P; Inadomi JM
    Arch Intern Med; 2002 Oct; 162(18):2105-10. PubMed ID: 12374519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse gastrointestinal effects of NSAIDs: consequences and costs.
    Bidaut-Russell M; Gabriel SE
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):739-53. PubMed ID: 11566038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.
    Lanza LL; Walker AM; Bortnichak EA; Dreyer NA
    Arch Intern Med; 1995 Jul; 155(13):1371-7. PubMed ID: 7794085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
    Laine L
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons.
    Griffin MR; Ray WA; Schaffner W
    Ann Intern Med; 1988 Sep; 109(5):359-63. PubMed ID: 3261560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
    Wilcox CM; Shalek KA; Cotsonis G
    Arch Intern Med; 1994 Jan; 154(1):42-6. PubMed ID: 8267488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for gastrointestinal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs).
    Agrawal N
    J Fam Pract; 1991 Jun; 32(6):619-24. PubMed ID: 2040888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.